Tema Heart & Health ETF Rating $29.68 +0.24 (+0.82%) As of 02:53 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Tema Heart & Health ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HRTS Aggregate RatingModerate Buy 2.72Holdings in HRTS have an aggregate rating of Moderate Buy based on 440 analyst ratings issued in the past year covering 21 companies (68.2% of the portfolio).HRTS Aggregate Price Target$29.68High Prediction$29.68Average Prediction$29.68Low Prediction$29.68Holdings in HRTS have an aggregate price target of $29.68 and a range of $29.68 to $29.68 covering 21 companies (68.2% of the portfolio).HRTS Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Tema Heart & Health ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 21 HRTS Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings10.06%LLYEli Lilly and Company$710.73+0.1%4.9993 of 5 stars2.65$950.17 33.7%23Trending News4.75%ABTAbbott Laboratories$132.41+0.3%4.907 of 5 stars2.91$144.47 9.1%22Positive News4.03%RHHBYRoche$40.87+1.0%N/A2.577Positive News3.55%GILDGilead Sciences$114.77-1.2%4.9726 of 5 stars2.88$115.39 0.5%26Trending NewsAnalyst Upgrade3.51%UNHUnitedHealth Group$307.10+1.2%4.9627 of 5 stars2.50$365.38 19.0%24Trending NewsAnalyst ForecastAnalyst Revision3.50%BBIOBridgeBio Pharma$49.08-2.3%4.6819 of 5 stars3.00$61.35 25.0%17Insider Trade3.48%MDTMedtronic$92.62+1.7%4.7086 of 5 stars2.68$101.15 9.2%19Trending NewsEarnings ReportDividend AnnouncementAnalyst ForecastAnalyst Revision3.47%ABBVAbbVie$210.28+0.4%4.7642 of 5 stars2.96$214.95 2.2%27Trending News3.34%BSXBoston Scientific$106.00+0.7%4.7209 of 5 stars3.04$117.50 10.9%26Positive News3.31%TMOThermo Fisher Scientific$500.24+3.4%4.9356 of 5 stars2.73$593.00 18.5%22Trending NewsInsider TradeAnalyst Revision2.83%VRTXVertex Pharmaceuticals$395.12-0.6%4.8599 of 5 stars2.56$497.10 25.8%27Positive News2.67%AMGNAmgen$293.72-0.7%4.7109 of 5 stars2.33$303.76 3.4%21Trending NewsInsider Trade2.51%CRNXCrinetics Pharmaceuticals$30.92+5.2%3.7079 of 5 stars2.78$68.86 122.7%9News CoveragePositive NewsInsider Trade2.49%MRKMerck & Co., Inc.$87.18+1.3%4.9741 of 5 stars2.35$107.44 23.2%20Positive News2.35%DHRDanaher$211.71+3.8%4.7362 of 5 stars2.85$247.61 17.0%20Positive News2.29%ALNYAlnylam Pharmaceuticals$454.38-2.8%4.1903 of 5 stars2.85$405.33 -10.8%26News CoverageInsider Trade2.18%REGNRegeneron Pharmaceuticals$589.48-1.5%4.858 of 5 stars2.81$829.65 40.7%26Positive NewsDividend Announcement2.05%PODDInsulet$330.77+0.9%4.3684 of 5 stars2.89$332.71 0.6%18Positive NewsAnalyst Forecast1.98%BMYBristol Myers Squibb$47.84-1.2%4.7834 of 5 stars2.24$56.38 17.8%21Trending News1.95%MCKMcKesson$687.71-2.6%4.1215 of 5 stars2.85$725.10 5.4%13Positive NewsInsider Trade1.93%EWEdwards Lifesciences$81.76+0.7%4.5075 of 5 stars2.65$85.90 5.1%26Positive NewsAnalyst Revision This page (NASDAQ:HRTS) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe $365M annual revenue crypto play While Bitcoin generates zero operational revenue, one DeFi protocol qu...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Heart & Health ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Heart & Health ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access